HIPO is expected to report earnings to fall 110.13% to -7 cents per share on November 11
Q3'26
Est.
$-0.08
Q2'26
Beat
by $0.97
Q4'25
Beat
by $0.46
Q3'25
Beat
by $4.18
Q2'25
Beat
by $0.65
The last earnings report on July 30 showed earnings per share of 79 cents, beating the estimate of -18 cents. With 139.31K shares outstanding, the current market capitalization sits at 875.60M.
A.I.dvisor indicates that over the last year, HIPO has been loosely correlated with LMND. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HIPO jumps, then LMND could also see price increases.
HIPO sees its 50-day moving average cross bullishly above its 200-day moving average
The 50-day moving average for HIPO moved above the 200-day moving average on August 19, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on August 28, 2026. You may want to consider a long position or call options on HIPO as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HIPO advanced for three days, in of 259 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 137 cases where HIPO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for HIPO moved out of overbought territory on August 07, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 48 cases where HIPO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for HIPO turned negative on August 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIPO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
HIPO broke above its upper Bollinger Band on August 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HIPO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.881) is normal, around the industry mean (2.160). P/E Ratio (7.045) is within average values for comparable stocks, (15.787). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.326). HIPO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.022). P/S Ratio (1.743) is also within normal values, averaging (1.611).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIPO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 51, placing this stock worse than average.
